Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Expert opinion on therapeutic patents - 22(2012), 4 vom: Apr., Seite 369-391 |
| Beteiligte Personen: |
Federico, Stephanie [VerfasserIn] |
|---|
| Umfang: |
22 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1892314347 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1892314347 | ||
| 003 | DE-627 | ||
| 005 | 20230515195450.0 | ||
| 007 | tu | ||
| 008 | 120405s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw120405_1 |
| 035 | |a (DE-627)OLC1892314347 | ||
| 035 | |a (DE-599)GBVOLC1892314347 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 100 | 1 | |a Federico, Stephanie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands |
| 264 | 1 | |c 2012 | |
| 300 | |a 22 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Spalluto, Giampiero |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on therapeutic patents |d London : Informa Healthcare, 1994 |g 22(2012), 4 vom: Apr., Seite 369-391 |w (DE-627)182204588 |w (DE-600)1186201-4 |x 1354-3776 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2012 |g number:4 |g month:04 |g pages:369-391 |g extent:22 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2012 |e 4 |c 4 |h 369-391 |g 22 | ||